West Orange, NJ, January 12, 2001 -- Organon Inc. today announced it received approval from the U.S Food and Drug Administration to market REMERON(r) SolTabTM (mirtazapine) Orally Disintegrating Tablet. REMERONSolTab is the first disintegrating tablet in the $7 billion U.S. antidepressant market.

Unlike all other antidepressant tablets, which must be swallowed whole, REMERONSolTab dissolves on the tongue within 30 seconds. This easy delivery method may enhance patient compliance as it can be swallowed with or without water, chewed or allowed to disintegrate.

According to the National Mental Health Association, clinical depression is one of the most common mental illnesses, affecting more than 19 million Americans each year. Unfortunately, fewer than half of those suffering from depression get the treatment they need -- and others stop treatment too soon.

Along with its now unique delivery system, REMERONSolTab has a novel pharmacological profile that increases the levels of both norepinephrine and serotonin in the brain to effectively fight depression; many antidepressants increase only serotonin.

REMERONSolTab is suitable for depressed patients of all ages. It has been proven effective in the relief of depression and its associated symptoms of anxiety, insomnia and reduced appetite, which may make it an ideal choice for the more
mature depressed patient.

---Spectrum Science

Back to The Science of Mental Health